GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

This study has been terminated.
(Study protocol amended to a new treatment regimen: study DAVFU-006.)
Sponsor:
Information provided by (Responsible Party):
Galectin Therapeutics Inc.
ClinicalTrials.gov Identifier:
NCT00110721
First received: May 12, 2005
Last updated: March 5, 2012
Last verified: March 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2008
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)